한미약품은 바이오신약, 차세대 표적 항암신약 등 개발에 매진하고 있습니다.
Incrementally modified drugs refer to medicines that have similar compounds to original drugs but have changed formulation or salt to increase safety and efficacy with greater convenience for patients.
Hanmi has been making a foray into the global market developing combination drugs, patented drug formulation and delivery platform technologies.
benign prostatic hyperplasia
asthma/rhinitis for pediatrics
NSAID-associated gastric ulcers